Native Meta creative and exact outbound link observed October 22, 2026. Redirects were followed to the captured public destination. Actual GLP-1 acquisition creative; peptide/sermorelin keyword searches showed no matches. Advertiser claims are source material; activity does not establish performance. No personal, health or payment details were entered.

A long care page develops a direct offer through product quality, treatment comparisons, care steps, customer stories and assessment entry. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
The headline picks a fight with a price the viewer has probably already seen in other GLP-1 ads, the $39 first month, and answers it with an itemized list that ends on compounded tirzepatide at $129/mo. The receipt format does the explaining for you: people read it like a bill and get that some offers leave the medication out. The copy repeats the promise in plain checkmarks (same price every dose, pay as you go, cancel anytime, doctor-guided care), so the image and text push one idea. Eden ran several versions of this creative from September 4, 2026.
The prices don't line up. The receipt totals $129 for tirzepatide while the ad headline and copy say $99, and nothing tells the viewer that $99 is semaglutide and $129 is tirzepatide (the landing page makes that split clear in its hero). Someone comparing prices, which is exactly who this ad is for, will notice and wonder which number is real. Label both medications on the receipt, or match the headline to the medication shown. The ad also has no reason to act now, so a line about the lifetime price guarantee the page mentions would give a price-checker something to lock in.
Putting the vial right under the total makes the price read as including the medication, which is the whole argument.
It names the teaser price the viewer already knows from other ads, so the comparison lands before they read anything else.
It restates the receipt's point as plain terms and adds the care promise the image can't show.
The headline and copy promise $99 a dose with no hidden fees and no annual prepay; the receipt inside the image shows tirzepatide at $129 a month.
The ad sends people to Eden's GLP-1 affiliate page, a focused landing page rather than the homepage, and the hero picks up the price promise right away: semaglutide at $99/mo and tirzepatide at $129/mo side by side under a monthly-pricing-at-every-dose label, with a Start my free assessment button. That assessment works like a quiz entry, so the next step is answering questions rather than checking out. Further down, the treatment comparison and the plan inclusions section carry on the receipt idea by spelling out what you get. The one snag is that the ad's $99 headline only gets resolved once the visitor sees two prices.
Eden's GLP-1 affiliate page is a long, focused landing page that opens on semaglutide at $99/mo and tirzepatide at $129/mo with a free assessment, then covers quality, treatment, care steps, stories and FAQs. All 16 Eden ads in the Fluid library link here, mostly price comparisons plus creator and doctor videos.
The headline, three benefits, both monthly prices and the free assessment button answer what it costs and how to start, with Trustpilot and member-count proof alongside.
It covers where the medication comes from and who oversees care, answering whether a low price means cutting corners.
It explains the problem and how the treatment is meant to work, answering why someone would consider it at all.
It compares treatment options so the visitor can work out which one fits before starting the assessment.
It walks through the steps from assessment to ongoing care, answering what happens after the click.
It shows stories from customers, answering whether people like the visitor have used the service.
It lists what the plan includes and repeats the assessment entry, answering what the monthly price covers right before asking again.
It handles remaining questions and the safety and compounding disclosures, answering the last objections before signing up.
Read the full breakdown of this page
One of 16 Eden ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.